Published in Circulation on July 01, 1986
Inoperable aortic stenosis in the elderly: benefit from percutaneous transluminal valvuloplasty. Br Med J (Clin Res Ed) (1987) 1.24
Balloon dilatation of heart valves. BMJ (1992) 1.20
Percutaneous balloon dilatation of calcific aortic valve stenosis: anatomical and haemodynamic evaluation. Br Heart J (1988) 0.94
Percutaneous aortic balloon dilatation for calcific aortic stenosis in elderly patients: immediate haemodynamic results and short-term follow up. Br Heart J (1987) 0.79
Balloon dilatation of the aortic valve: limited success and early restenosis. Br Heart J (1988) 0.78
Inoperable aortic stenosis in the elderly: benefit from percutaneous transluminal valvuloplasty. Br Med J (Clin Res Ed) (1987) 0.75
Balloon dilatation of the aortic valve in a pulsatile flow model: assessment of the mechanisms and the magnitude and duration of changes in valve area and gradient. Br Heart J (1990) 0.75
Balloon aortic valvuloplasty: the Texas Heart Institute experience. Tex Heart Inst J (1990) 0.75
Balloon aortic valvuloplasty. Indian Heart J (2016) 0.75
Recent advances in invasive cardiology. Can Fam Physician (1987) 0.75
[Decompensated valve failure: the revival of balloon valvuloplasty - percutaneous valve intervention]. Herz (2009) 0.75
Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation (1993) 9.24
Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest (1975) 5.72
Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med (2000) 4.67
Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res (1987) 3.86
Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer. J Natl Cancer Inst (1996) 3.45
Use of endovascular stents in congenital heart disease. Circulation (1991) 3.40
Baffle fenestration with subsequent transcatheter closure. Modification of the Fontan operation for patients at increased risk. Circulation (1990) 3.35
Double-umbrella closure of atrial defects. Initial clinical applications. Circulation (1990) 3.34
Increased coronary perforation in the new device era. Incidence, classification, management, and outcome. Circulation (1994) 3.30
A prospective study of benign breast disease and the risk of breast cancer. JAMA (1992) 3.29
Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system. J Clin Oncol (1999) 3.04
Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation (1992) 3.04
Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol (1995) 2.96
Paradoxical embolism. Diagnosis during life. Am J Med (1972) 2.85
Radiation exposure to patients undergoing diagnostic and interventional cardiac catheterization procedures. Cathet Cardiovasc Diagn (1997) 2.67
In-hospital mortality for surgical repair of congenital heart defects: preliminary observations of variation by hospital caseload. Pediatrics (1995) 2.60
Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin Cancer Res (1999) 2.55
Columnar alteration with prominent apical snouts and secretions: a spectrum of changes frequently present in breast biopsies performed for microcalcifications. Am J Surg Pathol (1998) 2.53
Implantation and intermediate-term follow-up of stents in congenital heart disease. Circulation (1993) 2.53
HER-2/neu protein expression in breast cancer evaluated by immunohistochemistry. A study of interlaboratory agreement. Am J Clin Pathol (2000) 2.53
Radial scars in benign breast-biopsy specimens and the risk of breast cancer. N Engl J Med (1999) 2.45
Randomised trial of fish oil for prevention of restenosis after coronary angioplasty. Lancet (1989) 2.28
Ventricular size and function assessed by cardiac MRI predict major adverse clinical outcomes late after tetralogy of Fallot repair. Heart (2006) 2.23
The relationship between shaved margin and inked margin status in breast excision specimens. Cancer (1997) 2.22
Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. Circulation (1986) 2.22
Evidence implicating nonmuscle myosin in restenosis. Use of in situ hybridization to analyze human vascular lesions obtained by directional atherectomy. Circulation (1992) 2.20
Neonatal critical valvar aortic stenosis. A comparison of surgical and balloon dilation therapy. Circulation (1989) 2.18
Percutaneous catheter commissurotomy in rheumatic mitral stenosis. N Engl J Med (1985) 2.18
Effect of reperfusion on biventricular function and survival after right ventricular infarction. N Engl J Med (1998) 2.12
In-utero intervention for hypoplastic left heart syndrome--a perinatologist's perspective. Ultrasound Obstet Gynecol (2005) 2.10
The creatine kinase system in normal and diseased human myocardium. N Engl J Med (1985) 2.06
Transcatheter closure of ventricular septal defects. Circulation (1988) 2.05
Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer. Hum Pathol (1992) 2.05
Hemodynamic assessment of amrinone. A new inotropic agent. N Engl J Med (1978) 2.03
Preoperative transcatheter closure of congenital muscular ventricular septal defects. N Engl J Med (1991) 2.00
p53 antigen loss in stored paraffin slides. N Engl J Med (1995) 1.99
Balloon dilation angioplasty of aortic coarctations in infants and children. Circulation (1983) 1.99
Hepatic venous blood and the development of pulmonary arteriovenous malformations in congenital heart disease. Circulation (1995) 1.97
Pathologic predictors of early local recurrence in Stage I and II breast cancer treated by primary radiation therapy. Cancer (1984) 1.95
Early results and medium-term follow-up of stent implantation for mild residual or recurrent aortic coarctation. Am Heart J (2000) 1.94
Transcatheter closure of coronary artery fistulas. J Am Coll Cardiol (1992) 1.93
Transcatheter ablation of ectopic atrial tachycardia in young patients using radiofrequency current. Circulation (1992) 1.92
Reflex increase in coronary vascular resistance in patients with ischemic heart disease. N Engl J Med (1976) 1.92
Dilation angioplasty of congenital or operative narrowings of venous channels. Circulation (1984) 1.91
Effect of baffle fenestration on outcome of the modified Fontan operation. Circulation (1992) 1.90
Percutaneous balloon valvotomy of congenital pulmonary stenosis using oversized balloons. J Am Coll Cardiol (1986) 1.89
Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol (2000) 1.89
Persistent sciatic artery: clinical, embryologic, and angiographic features. AJR Am J Roentgenol (1985) 1.88
Cardiac hypertrophy: useful adaptation or pathologic process? Am J Med (1980) 1.87
Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. Circulation (1987) 1.78
Predictors of event-free survival after balloon aortic valvuloplasty. N Engl J Med (1991) 1.78
Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer. J Clin Oncol (1999) 1.77
Contractile state of the left ventricle in man as evaluated from end-systolic pressure-volume relations. Circulation (1977) 1.77
Prevalence and risk factors for aortopulmonary collateral vessels after Fontan and bidirectional Glenn procedures. J Am Coll Cardiol (1993) 1.75
Fontan operation in five hundred consecutive patients: factors influencing early and late outcome. J Thorac Cardiovasc Surg (1997) 1.75
Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev (1997) 1.75
Microvessel density and distribution in ductal carcinoma in situ of the breast. J Natl Cancer Inst (1994) 1.75
Diagnostic accuracy of 99mTc-sestamibi breast imaging: multicenter trial results. J Nucl Med (2000) 1.73
Coronary atherectomy. Clinical, angiographic, and histological findings and observations regarding potential mechanisms. Circulation (1990) 1.73
Severe autologous GVHD after hematopoietic progenitor cell transplantation for multiple myeloma. Bone Marrow Transplant (2008) 1.72
The "laid-back" aortogram: an improved angiographic view for demonstration of coronary arteries in transposition of the great arteries. Am J Cardiol (1990) 1.71
The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol (1990) 1.71
Perforations after percutaneous coronary interventions: clinical, angiographic, and therapeutic observations. Cathet Cardiovasc Diagn (1994) 1.68
Percutaneous balloon mitral valvuloplasty in a pregnant woman with mitral stenosis. Cathet Cardiovasc Diagn (1988) 1.65
Assessment of pathologic prognostic factors in breast core needle biopsies. Mod Pathol (1999) 1.65
Conversion of modified Fontan procedure to lateral atrial tunnel cavopulmonary anastomosis. J Thorac Cardiovasc Surg (1996) 1.60
Diastolic properties of the left ventricle. Ann Intern Med (1976) 1.59
Front-loading of double-umbrella devices, a new technique for umbrella delivery for closing cardiovascular defects. Am J Cardiol (1992) 1.56
Treatment of no-reflow in degenerated saphenous vein graft interventions: comparison of intracoronary verapamil and nitroglycerin. Cathet Cardiovasc Diagn (1996) 1.54
Fibrinolytic therapy for femoral arterial thrombosis after cardiac catheterization in infants and children. Am J Cardiol (1986) 1.54
Papillary lesions of the breast: selected diagnostic and management issues. Histopathology (2008) 1.53
Developing a prognostic index for ductal carcinoma in situ of the breast. Are we there yet? Cancer (1996) 1.53
Balloon dilation angioplasty of hypoplastic and stenotic pulmonary arteries. Circulation (1983) 1.53
Expression of interleukin-1beta in human breast carcinoma. Cancer (1997) 1.52
Current complications of diagnostic and therapeutic cardiac catheterization. J Am Coll Cardiol (1988) 1.51
Quantitative evaluation of HER-2/neu status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysis. Am J Clin Pathol (2001) 1.51
Patent foramen ovale is indicted, but the case hasn't gone to trial. Circulation (2000) 1.50
Morphologic changes induced by dilation of the pulmonary valve anulus with overlarge balloons in normal newborn lambs. Am J Cardiol (1985) 1.50
Enhanced intracoronary thrombolysis with urokinase using a novel, local drug delivery system. In vitro, in vivo, and clinical studies. Circulation (1995) 1.50
Expression of scatter factor and c-met receptor in benign and malignant breast tissue. Cancer (1997) 1.50
Coil embolization to occlude aortopulmonary collateral vessels and shunts in patients with congenital heart disease. J Am Coll Cardiol (1989) 1.50
An 11 year evolution of coronary arterial surgery (1968-1978). Ann Surg (1979) 1.49
Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. Cancer (1996) 1.49
Autologous blood donations prior to elective cardiac surgery. Safety and effect on subsequent blood use. JAMA (1989) 1.48
Early results and follow-up of balloon angioplasty for branch pulmonary artery stenoses. J Am Coll Cardiol (1990) 1.48
Late prognosis of acute pulmonary embolism. N Engl J Med (1973) 1.47
Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension. Circulation (2001) 1.46
Factors associated with regional nodal failure in patients with early stage breast cancer with 0-3 positive axillary nodes following tangential irradiation alone. Int J Radiat Oncol Biol Phys (1999) 1.46
Skin-sparing mastectomy and immediate reconstruction: oncologic risks and aesthetic results in patients with early-stage breast cancer. Plast Reconstr Surg (1998) 1.44
Features and outcome of no-reflow after percutaneous coronary intervention. Am J Cardiol (1995) 1.43
Hereditary hemorrhagic telangiectasia presenting in early childhood. J Pediatr Gastroenterol Nutr (1994) 1.41
Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast. Cancer (1997) 1.40
Transcatheter umbrella closure of valvular and paravalvular leaks. J Am Coll Cardiol (1992) 1.40
Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study. Circulation (2000) 1.39